Login
Login
Sign Up

Real Clinics. Real Patients. Real Oncology.

Home/ News
Recent Updates

UGN-102 Shows Durable Response for Recurrent Low-Grade Bladder Cancer

In the phase 3 ENVISION trial, UGN-102 delivered durable responses and bladder-sparing treatment for recurrent low-grade IR-NMIBC.

August 17, 2026

Recent Updates

The latest breakthroughs, research highlights, and industry developments in oncology.

View More
Recent Updates

UGN-102 Shows Durable Response for Recurrent Low-Grade Bladder Cancer

August 17, 2026
Recent Updates

Researchers Find a Minimally Invasive Option for Recurrent NMIBC

August 10, 2026

FDA Approvals

Updates on recent FDA approvals, label expansions, and regulatory decisions that may affect everyday oncology practice.

View More
FDA Approvals

Emory Research Helps Lead to New FDA-Approved Treatment For Aggressive Breast Cancer

August 10, 2026
Image without description (no attachment ID found)
FDA Approvals

Quadruplet Regimen Approved for Transplant-Ineligible NDMM Patients

April 16, 2026

Clinical Trials

Stay current on pivotal oncology trials with practice-changing results, recruiting studies, and key readouts relevant to community cancer care.

View More
Clinical Trials

New Trial Data Reshaping Patient Selection for Bladder Cancer Maintenance Immunotherapy

July 14, 2026
Image without description (no attachment ID found)
Clinical Trials

MM BCG Plus Mitomycin: A Practical Alternative Amid Global BCG Shortage

July 14, 2026

What are you
looking for?

POPULAR SEARCHES

Bladder Cancer

Blood-Based Tests

Breast Cancer

Cancer Types